Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2003
03/13/2003WO2002022799A3 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof
03/13/2003WO2002022686A3 Defensin-antigen fusion proteins
03/13/2003WO2002020757A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002014471A3 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
03/13/2003WO2002008432A3 Composition and method for increased meiotic recombination in plants
03/13/2003WO2002008401A3 Elongase genes and uses thereof
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002002635A3 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001085946A3 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030051271 DNA sequences for an amino acid transporter plasmids, bacteria, yeasts and plants containing a transporter and their use
03/13/2003US20030051263 Genetic inhibition by double-stranded RNA
03/13/2003US20030050471 Antibiotic for use in the treatment and prevention of infections
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050456 Nucleotide sequences coding polypeptide for use in the treatment of brain and psychological disorders
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030050442 62 human secreted proteins
03/13/2003US20030050439 Polypeptide for use in the treatment of tumors and warts
03/13/2003US20030050230 A nucleic acid encoding a family (title) of kinases from a group of sixteen polypeptides; identifying a substance that modulates kinase activity; autoimmune diseases; organ transplantation, cardiovascular disease, stroke, renal failure
03/13/2003US20030049846 Plasmid to be used in chromosome recombination of escherichia coli
03/13/2003US20030049842 Nucleotide sequences coding polypeptide for use in gene therapy and treatment of viral diseases
03/13/2003US20030049835 Methods and means for producing efficient silencing construct using recombinational cloning
03/13/2003US20030049832 Bacillus for use in the efficiently degradation of fats, oils and grease
03/13/2003US20030049831 Protein for use in the prevention of infections
03/13/2003US20030049829 Concentration and lysis of adenovirus-infected cells in a single unit operation
03/13/2003US20030049827 Subtilisin variants
03/13/2003US20030049818 Polypeptide complex having DNA recombination activity
03/13/2003US20030049815 Recombinant bacterial phytases and uses thereof
03/13/2003US20030049807 Micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities
03/13/2003US20030049806 Polyhydroxyalkanoate synthase and gene encoding the same enzyme
03/13/2003US20030049805 Methylobacillus for use in the fermentation of lysine
03/13/2003US20030049804 Corynebacterium glutamicum genes encoding metabolic pathway proteins
03/13/2003US20030049803 Generation of amino acids in nutrient broth; prepare nutrient broth, inoculate with genetically engineered bacteria, propagate, express vector containing enzymes associated with amino acid, recover amino acids
03/13/2003US20030049802 Nucleotide sequences coding for the thrE gene and process for the enzymatic production of L-threonine using coryneform bacteria
03/13/2003US20030049797 Hybrid proteins for autoimmune disease
03/13/2003US20030049794 DNA encoding a human dopamine D1 receptor and uses thereof
03/13/2003US20030049791 Goodpasture antigen binding protein
03/13/2003US20030049790 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/13/2003US20030049786 Transducin beta-1 subunit
03/13/2003US20030049785 Expression vector for improved production of polypeptides in yeast
03/13/2003US20030049784 Tissue factor for use in the treatment of clotting, thrombotic, cardiovascular and cancer disorders
03/13/2003US20030049736 Regulatory sequences for use in genetic engineering and controlling gene expression
03/13/2003US20030049735 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049731 Plasmid for use as tool in genetic engineering and heterologous gen expression
03/13/2003US20030049729 Generation of genetically engineered tissue plasminogen activator; obtain cells, incubate with vector, transform cells, express vector, recover tissue plasminogen activator
03/13/2003US20030049728 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
03/13/2003US20030049723 MAGE-A3 peptides presented by HLA class II molecules
03/13/2003US20030049720 Process for producing carotenoids and biological materials useful therefor
03/13/2003US20030049718 Plating media for the presumptive identification of the genus Shigella and the species Shigella sonnei and shigella boydii
03/13/2003US20030049717 Products comprising quantum of bioparticles and method for production thereof
03/13/2003US20030049712 Detct of protease activity in cell; obtain sample containing labeled enzymatic fusion protein, incubate with cell, detecting the subcellular position of label domain
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander
03/13/2003US20030049690 Detection of DNA damaging agents
03/13/2003US20030049688 Protein fragment complementation assays for the detection of biological or drug interactions
03/13/2003US20030049686 Generation of mutant protein library; obtain nucleotide sequences coding mutant proteins, incubate with cells, transform cells, recover transformed cells, propagate, recover cloned sequences coding mutant protein
03/13/2003US20030049683 Rationally designed antibodies
03/13/2003US20030049669 Protein for use in detection of bacterial infections
03/13/2003US20030049651 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer
03/13/2003US20030049648 37 staphylococcus aureus genes and polypeptides
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049605 Display of viral proteins
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049603 Designing preferential chemokines; obtain phage display library, incubate with cells, harvest cells, release phage, incubate with bacteria and clone phage, recover clones
03/13/2003US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049270 Hybrid nucleotide sequence
03/13/2003US20030049269 Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
03/13/2003US20030049265 Heliobacter pylori antigen
03/13/2003US20030049263 Vaccine; nucleotide sequences
03/13/2003US20030049243 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests
03/13/2003US20030049241 Astaxanthin over-producing strains of phaffia rhodozyma, methods for their cultivation and their use in animal feeds
03/13/2003US20030049237 Isolated nucleic acids; prevent binding of antigens; peanut allergies
03/13/2003US20030049231 Therapy for skin disorders; human or veterinary medicine
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003CA2459777A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458953A1 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003CA2458879A1 Genetic construct intracellular monitoring system
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/13/2003CA2457038A1 Identification of eukaryotic internal ribosome entry site (ires) elements
03/13/2003CA2456718A1 Creation of artificial internal ribosome entry site (ires) elements
03/13/2003CA2455435A1 Identification of sortase gene
03/13/2003CA2455084A1 Genes encoding baeyer-villiger monooxygenases
03/12/2003EP1291435A2 A micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities
03/12/2003EP1291432A1 Novel promoters and gene expression method by using the promoters
03/12/2003EP1291431A1 Endoglucanase nce5 and cellulase preparations containing the same